Sec. 1. (a) Subject to federal law and consistent with standard medical practice in opioid treatment of drug abuse, the division shall adopt rules under IC 4-22-2 to establish and administer an opioid treatment diversion control and oversight program to identify individuals who divert opioid treatment medications from legitimate treatment use and to terminate the opioid treatment of those individuals.

     (b) Rules adopted under subsection (a) must include provisions relating to the following matters concerning opioid treatment programs and patients who receive opioid treatment:

(1) Regular clinic attendance by the patient.

(2) Specific counseling requirements for the opioid treatment program.

(3) Serious behavior problems of the patient.

(4) Stable home environment of the patient.

(5) Safe storage capacity of opioid treatment medications within the patient’s home.

(6) Medically recognized testing protocols to determine legitimate opioid treatment medication use.

(7) The opioid treatment program’s medical director and administrative staff responsibilities for preparing and implementing a diversion control plan.

As added by P.L.11-2003, SEC.2. Amended by P.L.116-2008, SEC.3.